Scireq Scientific Respiratory Equipment Inc.

Scireq Scientific Respiratory Equipment Inc., doing business as Scireq, manufactures and supplies specialized respiratory research equipment and inhalation exposure systems to federal research agencies as a prime contractor on full-and-open purchase orders, with no participation in set-aside vehicles. Based in Montreal, Quebec, Canada (with a secondary address listed as Baltimore, Maryland in some source materials), Scireq is a for-profit corporate entity registered in SAM.gov since 2008 that competes exclusively on the open market across 23 distinct federal customer agencies without small business designations or set-asides.

Scireq's concrete capability footprint centers on advanced respiratory measurement and inhalation exposure systems for preclinical biomedical research. The vendor manufactures FlexiVent and FlexiVent FX mechanical ventilation platforms for measuring respiratory mechanics in small animal models (airway resistance, compliance, tissue elastance), whole-body and nose-only plethysmography systems for lung-function assessment, inExpose inhalation exposure systems capable of aerosolizing compounds including tobacco smoke, diesel particulate matter, and dioxins for animal toxicology studies, and VivoFlow plethysmography for non-invasive airway-responsiveness evaluation. Representative recent work includes a $59,944 FlexiVent FX Complete System Solution to the Navy's Bureau of Medicine and Surgery (July 2025) for expeditionary medical research on inhalation toxicology, a $142,370 inExpose equipment order from CDC Pittsburgh (August 2024), a $82,829 inExpose rodent smoke machine to VA Veterans Integrated Service Network 7 (August 2024), a $46,890 VivoFlow Plethysmography system to the Office of Research and Development (May 2025), and a $39,260 inExpose inhalation exposure system to VA Veterans Integrated Service Network 4 (September 2025) for whole-body tobacco smoke exposure studies.

Customer concentration is distributed across health research agencies rather than consolidated. CDC Pittsburgh ranks first by both award count and dollar value (7 awards, $266 thousand combined potential value), followed by the National Heart Lung and Blood Institute (6 awards, $156 thousand), the National Institute of Environmental Health Sciences (6 awards, $99 thousand), and multiple VA Veterans Integrated Service Networks (combined 8 awards across Networks 4, 7, and 22 totaling $590 thousand). The National Institute of Allergy and Infectious Diseases and Army Medical Command also appear as material customers by potential value at $232 thousand and $227 thousand respectively. The top five customers by either ranking account for 40–42% of awards and dollars, indicating a broad agency footprint rather than narrow concentration.

Scireq operates exclusively as a prime contractor (100% of 67 tracked awards). Recent activity shows modest volume — three awards each in 2025 and 2026, after four awards in both 2023 and 2024 — with only two awards (combined potential value $104 thousand) reaching ultimate completion in the next twenty-four months, limiting near-term recompete exposure. All awards are firm fixed-price purchase orders under FAR Part 12 commercial-item procedures; the vendor qualifies as an exclusive manufacturer and distributor of proprietary respiratory platforms that trigger sole-source procurements under simplified acquisition authority. The broader award portfolio across 67 total awards since 2006 totals $2.6 million in combined potential and obligated value, concentrated under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) for 46 awards and PSC Laboratory Equipment and Supplies for 44 awards.